{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:37:33Z","timestamp":1761917853060},"reference-count":45,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.2169\/internalmedicine.9481-17","type":"journal-article","created":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T22:15:39Z","timestamp":1514326539000},"page":"1229-1240","source":"Crossref","is-referenced-by-count":21,"title":["Changes in Antidiabetic Drug Prescription and Glycemic Control Trends in Elderly Patients with Type 2 Diabetes Mellitus from 2005-2013: An Analysis of the National Center Diabetes Database (NCDD-03)"],"prefix":"10.2169","volume":"57","author":[{"given":"Ritsuko","family":"Yamamoto-Honda","sequence":"first","affiliation":[{"name":"Department of Diabetes Research and Diabetes and Metabolism Information Center, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Japan"},{"name":"Health Management Center, Toranomon Hospital, Japan"},{"name":"Department of Endocrinology and Metabolism, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Center Hospital, Japan"},{"name":"Division of Diabetes and Metabolism, Iwate Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumichi","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, JR Tokyo General Hospital, Japan"},{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Tokyo Yamate Medical Center, Japan Community Health Care Organization, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Diabetes, the Institute for Adult Diseases, Asahi Life Foundation, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Kawazu","sequence":"additional","affiliation":[{"name":"Department of Diabetes, the Institute for Adult Diseases, Asahi Life Foundation, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Diabetes, the Institute for Adult Diseases, Asahi Life Foundation, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kajio","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Center Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekatsu","family":"Yanai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Center for Global Health and Medicine Kohnodai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Mishima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Center for Global Health and Medicine Kohnodai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Handa","sequence":"additional","affiliation":[{"name":"Nagara Medical Center, National Hospital Organization, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Yutenji Medical Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Kanamachi Yoshida Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"National Hospital Organization, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Ohe","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Economics, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Shimbo","sequence":"additional","affiliation":[{"name":"Ohta Nishinouchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Diabetes Research and Diabetes and Metabolism Information Center, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Japan"},{"name":"Department of Endocrinology and Diabetes, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301: 2129-2140, 2009.","DOI":"10.1001\/jama.2009.726"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Namakura J, Kamiya H, Haneda M, et al. Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010. -Report from the Committee on the Causes of Death in Diabetes Mellitus. J Diabetes Int 8: 397-410, 2017.","DOI":"10.1111\/jdi.12645"},{"key":"3","unstructured":"3. Haneda M, Ito H; Japan Diabetes Society (JDS)\/Japan Geriatrics Society (JGS) Joint Committee on Improving Care for Elderly Patients with Diabetes. Committee report: glycemic targets for elderly patients with diabetes. Diabetol Int 7: 331-333, 2016."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yamamoto-Honda R, Takahashi Y, Yamashita S, et al. Constructing the National Center Diabetes Database. Diabetol Int 5: 234-243, 2014.","DOI":"10.1007\/s13340-014-0162-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kosaka K. Diagnostic criteria for diabetes mellitus in Japan-from a report of the Japan Diabetes Society (JDS) Committee on the Diagnosis of Diabetes Mellitus, 1982. Diabetes Res Clin Pract 24: S59-S62, 1994.","DOI":"10.1016\/0168-8227(94)90228-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kuzuya T, Nakagawa S, Satoh J, et al.; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 55: 65-85, 2002.","DOI":"10.1016\/S0168-8227(01)00365-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Seino Y, Nanjo N, Tajima N, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Diabetol Int 1: 2-20, 2010.","DOI":"10.1007\/s13340-010-0006-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Duckworth WC, Abraira C, Moritz TE, et al.; Investigators of the VADT. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: The VA Diabetes Trial. J Diabetes Complications 25: 355-361, 2011.","DOI":"10.1016\/j.jdiacomp.2011.10.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Oishi M, Yamazaki K, Okuguchi F, Sugimoto H, Kanatsuka A, Kashiwagi A. Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32). J Diabetes Invest 5: 581-587, 2014.","DOI":"10.1111\/jdi.12183"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kohoro T, Yamazaki T, Sato H, et al. Trends in antidiabetic prescription patterns in Japan from 2005 to 2011. Int Heart J 54: 93-97, 2013.","DOI":"10.1536\/ihj.54.93"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hampp C, Borders-Hemphill V, Money DG, Wysowski DK. Use of antidiabetic drugs in the U.S., 2003-2012. Diabetes Care 34: 1367-1374, 2014.","DOI":"10.2337\/dc13-2289"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chiristensen DH, Rungby J, Thomsen RW. Nationwide trends in glucose-lowering drug use, Denmark, 1999-2014. Clin Epidemiol 8: 381-387, 2016.","DOI":"10.2147\/CLEP.S113211"},{"key":"13","doi-asserted-by":"crossref","first-page":"e012463","DOI":"10.1136\/bmjopen-2016-012463","volume":"6","author":"M Mata-Cases","year":"2016","unstructured":"13. Mata-Cases M, Franch-Nadal J, Real J, Maurico D. Glycemic control and antidiabetic treatment trends in primary care centers in patients with type 2 diabetes mellitus during 2007-2013 in Catalonia: a population-based study. BMJ Open 6: e012463, 2016.","journal-title":"BMJ Open","ISSN":"http:\/\/id.crossref.org\/issn\/2044-6055","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ko SH, Kim DJ, Park CY, et al.; Task Force Team for Diabetes Fact Sheet of the Korean Diabetes Association. Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study. Medicine (Baltimore) 95: e4018, 2016.","DOI":"10.1097\/MD.0000000000004018"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lipska KJ, Yao X, Herrin J, et al. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006-2013. Diabetes Care 40: 468-475, 2017.","DOI":"10.2337\/dc16-0985"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Turner LW, Nartey D, Stafford RS, Singh S, Alexander GC. Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012. Diabetes Care 37: 985-992, 2014.","DOI":"10.2337\/dc13-2097"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Clemens KK, Shariff S, Liu K, et al. Trends in antihyperglycemic medication prescriptions and hypoglycemia in older adults: 2002-2013. PLoS One 10: e0137596, 2015.","DOI":"10.1371\/journal.pone.0137596"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yotsapon T, Sirinate K, Ekgaluck W, et al. Clinical characteristics and outcomes of the oldest old people with type 2 diabetes - perspective from a tertiary diabetes center in Thailand. BMC Endocr Disord 16: 30, 2016.","DOI":"10.1186\/s12902-016-0115-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zhang L, Ji L, Guo L, et al. Treatment patterns and glycemic control in older adults with type 2 diabetes mellitus receiving only oral antidiabetes drugs in China. Diabetes Technol Ther 17: 816-824, 2015.","DOI":"10.1089\/dia.2015.0094"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Kim YG, Hahn S, Oh TJ, Kwak SH, Park KS, Cho YM. Differences in the glucose-lowering efficacy of dipeptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis. Diabetologia 56: 696-708, 2013.","DOI":"10.1007\/s00125-012-2827-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. The American Diabetes Association (eds.) Standards of medical care in diabetes-2017. Pharmacologic approaches to glycemic treatment. Diabetes Care 40 (Supple 1): S64-S74, 2017.","DOI":"10.2337\/dc17-S011"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tajima N, Noda M, Origasa H, et al. Evidence-based practice guideline for the treatment for diabetes in Japan 2013. Diabetol Int 6: 151-187, 2015.","DOI":"10.1007\/s13340-015-0206-2"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Moller JB, Pedersen M, Tanaka H, et al. Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Caucasians. Diabetes Care 37: 796-804, 2014.","DOI":"10.2337\/dc13-0598"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Yoshinaga H, Kosaka K. Heterogenous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity. Diabetes Res Clin Pract 44: 129-136, 1999.","DOI":"10.1016\/S0168-8227(99)00019-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yamamoto-Honda R, Osame K, Kitazato H, et al. Insulin secretion and insulin sensitivity in Japanese patients with Type 2 diabetes: a cross-sectional study comparing the homeostasis model assessment-2 (HOMA-2) indexes derived from the oral glucose tolerance test. Diabetology Int 2: 72-78, 2011.","DOI":"10.1007\/s13340-011-0024-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Harashima SI, Ogura M, Tanaka D, et al. Sitagliptin add-on low dosage sulphonylureas: efficacy and safety of combination therapy on glycemic control and insulin secretion capacity in type 2 diabetes. Int J Clin Pract 66: 465-476, 2012.","DOI":"10.1111\/j.1742-1241.2012.02903.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Umahaya R, Yonemoto T, Kyou C, et al. Low-dose glimepiride with sitagliptin improves glycemic control without dose-dependency in patients with type 2 diabetes inadequately controlled on high-dose glimepiride. Endocr J 61: 1163-1170, 2014.","DOI":"10.1507\/endocrj.EJ14-0233"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Muller N, Khunti K, Kuss O, et al. Is there evidence of potential overtreatment of glycemia in elderly people with type 2 diabetes? Data from the GUIDANCE study. Acta Diabetol 54: 209-214, 2017.","DOI":"10.1007\/s00592-016-0939-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117, 1995.","DOI":"10.1016\/0168-8227(95)01064-K"},{"key":"30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group null","year":"1998","unstructured":"30. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998.","journal-title":"The Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359: 1577-1589, 2008.","DOI":"10.1056\/NEJMoa0806470"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572, 2008.","DOI":"10.1056\/NEJMoa0802987"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J. Diabetes and infection: assessing the association with glycemic control in population-based studies. Lancet Diabetes Endocrinol 4: 148-158, 2016.","DOI":"10.1016\/S2213-8587(15)00379-4"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. McGovern AP, Hine J, de Lusingnan S. Infection risk in elderly people with reduced glycemic control. Lancet Diabetes Endocrinol 4: 303-304, 2016.","DOI":"10.1016\/S2213-8587(16)00043-7"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med 268: 471-482, 2010.","DOI":"10.1111\/j.1365-2796.2010.02265.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Landman GW, van Hateren KJ, Kleefstra N, Groenier KH, Gans RO, Bilo HJ. The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11). Br J Gen Pract 60: 172-175, 2010.","DOI":"10.3399\/bjgp10X483517"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Sluik D, Boeing H, Montonen J, et al. HbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitus. PLoS one 7: e38877, 2012.","DOI":"10.1371\/journal.pone.0038877"},{"key":"38","first-page":"375","volume":"2010","author":"CJ Currie","year":"2010","unstructured":"38. Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA (1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 2010: 375, 481-489, 2010.","journal-title":"The Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Huang ES, Liu JY, Moffet HH, John PM, Karter AJ. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care 34: 1329-1336, 2011.","DOI":"10.2337\/dc10-2377"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Miller ME, Bonds DE, Gerstein HC, et al.; ACCORD Investigators. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study. BMJ 340: b5444, 2010.","DOI":"10.1136\/bmj.b5444"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Araki A, Iimuro S, Sakurai T, et al; Japanese Elderly Intervention Trial Research Group. Non-high-density lipoprotein cholesterol: an important predictor of stroke and diabetes-related mortality in Japanese elderly diabetic patients. Geriatr Gerontol Int 12 (Suppl 1): 18-28, 2012.","DOI":"10.1111\/j.1447-0594.2011.00809.x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Cukierman-Yaffe T, Gerstein HC, Williamson JD, et al. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 32: 221-226, 2009.","DOI":"10.2337\/dc08-1153"},{"key":"43","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2009.460","volume":"301","author":"RA Whitmer","year":"2009","unstructured":"43. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301: 1565-1572, 2009.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Lin CH, Sheu WH. Hypoglycemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J Intern Med 273: 102-110, 2013.","DOI":"10.1111\/joim.12000"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Kirkman MS, Briscoe VJ, Clark N, et al.; Consensus development conference on diabetes and older adults. Diabetes in older adults: a consensus report. J Am Geriat Soc 60: 2342-2356, 2012.","DOI":"10.1111\/jgs.12035"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/9\/57_9481-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T18:30:10Z","timestamp":1570559410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/9\/57_9481-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9481-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]}}}